Literature DB >> 25056611

Targeted testing in primary care demonstrates high prevalence of hepatitis B infection within the Slovak-Roma population in Sheffield, UK.

A Gregory1, A Vedio, B Stone, S Green, C Bronsdon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25056611     DOI： 10.1111/jvh.12287

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN： 1352-0504            Impact factor:   3.728


× No keyword cloud information.
  5 in total

1.  Migrant health.

Authors:  David Bernard Lehane; Alicia Vedio; Ann Gregory; Caroline Mitchell
Journal:  Br J Gen Pract       Date:  2016-08       Impact factor: 5.386

2.  Prevalence and Risk Factors for Hepatitis B Virus Infection in Roma and Non-Roma People in Slovakia.

Authors:  Sylvia Drazilova; Martin Janicko; Pavol Kristian; Ivan Schreter; Monika Halanova; Ingrid Urbancikova; Andrea Madarasova-Geckova; Maria Marekova; Daniel Pella; Peter Jarcuska
Journal:  Int J Environ Res Public Health       Date:  2018-05-22       Impact factor: 3.390

3.  The Roma Population Living in Segregated Settlements in Eastern Slovakia Has a Higher Prevalence of Metabolic Syndrome, Kidney Disease, Viral Hepatitis B and E, and Some Parasitic Diseases Compared to the Majority Population.

Authors:  Zelmira Macejova; Pavol Kristian; Martin Janicko; Monika Halanova; Sylvia Drazilova; Daniela Antolova; Maria Marekova; Daniel Pella; Andrea Madarasova-Geckova; Peter Jarcuska; HepaMeta Team
Journal:  Int J Environ Res Public Health       Date:  2020-04-29       Impact factor: 3.390

Review 4.  Hepatotropic viruses: Is Roma population at risk?

Authors:  Anna Mrzljak; Lucija Bajkovec; Tatjana Vilibic-Cavlek
Journal:  World J Gastroenterol       Date:  2021-01-14       Impact factor: 5.742

5.  Low hepatitis B testing among migrants: a cross-sectional study in a UK city.

Authors:  Iro Evlampidou; Matthew Hickman; Charles Irish; Nick Young; Isabel Oliver; Sophie Gillett; Alexandra Cochrane
Journal:  Br J Gen Pract       Date:  2016-03-29       Impact factor: 5.386
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.